Regeneron Archives - Pharmaphorum

Sanofi gets opt-in rights to two Regeneron cancer drugs

https://pharmaphorum.com/news/sanofi-gets-opt-in-rights-to-two-regeneron-cancer-drugs/

Praluent not worth the price, finds study

https://pharmaphorum.com/news/praluent-not-worth-the-price-finds-study/

Amgen cuts US price of cholesterol drug by 60%

https://pharmaphorum.com/news/amgen-cuts-us-price-of-cholesterol-drug-by-60/

FDA approves Sanofi/Regeneron’s Dupixent in asthma

https://pharmaphorum.com/news/fda-approves-sanofi-regenerons-dupixent-in-asthma/

Sanofi/Regeneron’s Dupixent could be first biologic approved for nasal polyps

https://pharmaphorum.com/news/sanofi-regenerons-dupixent-could-be-first-biologic-approved-for-nasal-polyps/

Regeneron/Teva pain drug fasinumab on target in phase 3

https://pharmaphorum.com/news/regeneron-teva-pain-drug-fasinumab-target-phase-3/

Regeneron forges CAR-T R&D partnership with bluebird bio

https://pharmaphorum.com/news/regeneron-forges-car-t-rd-partnership-with-bluebird-bio/

Amgen’s Repatha gets EU cardio risk reduction label

https://pharmaphorum.com/news/amgens-repatha-gets-eu-cardio-risk-reduction-label/

Regeneron and Alnylam seek RNAi therapies for NASH

https://pharmaphorum.com/news/regeneron-alnylam-seek-rnai-therapies-nash/

Search